MarketWatch5d
AbbVie Inc. stock rises Tuesday, still underperforms market
Shares of AbbVie Inc. ABBV inched 0.60% higher to $201.68 Tuesday, on what proved to be an all-around great trading ...
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy Right Now?
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
AbbVie: 3 Positives From The Earnings Report
With growth catalysts in place, along with dividend payouts, AbbVie is a good medium to long-term buy. Click here to read an ...
bovnews6d
The AbbVie Inc Stock Thriller: Decoding the Mystery Behind ABBV’s Recent Movements
On Friday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $203.55 which represents a decrease of $-0.32 or -0.16% from the prior close of $203.87. The stock opened at $204.37 and touched a ...
Truist Financial Sticks to Its Buy Rating for AbbVie (ABBV)
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on AbbVie (ABBV – Research Report). The ...
Barchart on MSN4d
Are Wall Street Analysts Bullish on AbbVie Stock?
With a market cap of $356.2 billion, North Chicago, Illinois-based AbbVie Inc. (ABBV) operates in the pharmaceutical sector.
3 Spectacular High-Yield Dividend Stocks to Buy in November
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Business Insider12d
AbbVie Boosts FY24 Outlook; Boosts Dividend 5.8% - Update
(RTTNews) - While reporting financial results for the third quarter on Wednesday, biopharmaceutical company AbbVie, Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2024.